Latest Achillion Pharmaceuticals (ACHN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Achillion Pharmaceuticals (ACHN) Headlines

Narrower-than-Expected Loss at Achillion, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:30AM CDT
The share price of Achillion Pharmaceuticals fell slightly after the company announced its fourth-quarter results.

Achillion Pharmaceuticals ' net loss widens to USD59.0m in 2013
M2 - Mon Mar 10, 7:41AM CDT
US-based biopharmaceutical company Achillion Pharmaceuticals (NasdaqGS :ACHN) announced on Friday a net loss of USD59.0m for the 12 months ended 31 December 2013.

Achillion Reports 2013 Fourth Quarter and Year-End Financial Results
GlobeNewswire - Fri Mar 07, 5:05AM CST
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and twelve months ended December 31, 2013.

Achillion Hasn't Stopped Aching
at The Street - Tue Mar 04, 3:42PM CST
It's a mistake to buy these shares before any real announcement about when the new hepatitis-C drugs will come to market.

5 Stocks Gearing Up for Monster Short Squeezes
at The Street - Fri Feb 28, 7:12AM CST
These heavily shorted stocks could get squeezed higher on any positive catalyst

The 10 Most Heavily Shorted Bio-Pharma Stocks
at The Street - Mon Feb 24, 9:39AM CST
The No. 1 stock on this list has more than half its float short.

Achillion Pharmaceuticals, Inc. (ACHN) Soars: Stock Up 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 7:51AM CST
Achillion Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 10% on the day.

Mattersight Announces Fourth Quarter 2013 Results
Marketwire - Wed Feb 12, 3:44PM CST
Mattersight Corporation (NASDAQ: MATR) today announced financial results for the fourth quarter ended December 31, 2013.

Achillion to Present at Two Upcoming Investor Conferences
GlobeNewswire - Mon Feb 10, 5:00AM CST
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two upcoming investor conferences:

Nigeria Tops AJC First Leg Qualifiers
by Orkula Shaagee - All Africa Global Media - Fri Jan 17, 3:38AM CST
Team Nigeria was in comfortable lead yesterday as the first leg of the 2014 African Junior Tennis Championship (AJC) qualifiers ended at the Abuja National Stadium yesterday.

Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos
PR Newswire - Mon Jan 13, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Alere Inc. (NYSE: ALR), ARCA biopharma, Inc. (NASDAQ: ABIO), Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), and Receptos, Inc. (NASDAQ: RCPT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones
GlobeNewswire - Mon Jan 13, 5:25AM CST
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported progress on the Company's portfolio of proprietary compounds for the treatment of chronic hepatitis C (HCV) and outlined its 2014 milestones.

Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 8:04AM CST
Achillion Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise over 13% on the day.

Patients Enrolled in Synageva Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 3:15PM CST
Synageva finished enrolling patients for its phase III study on sebelipase alfa.

Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 8:25AM CST
Exelixis was a big mover last session, with shares rising over 11%.

Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 8:04AM CST
Athersys, Inc. was a big mover last session, as the company saw its shares rise by over 6% on the day.

5 Stocks Poised for Breakouts
at The Street - Fri Jan 03, 2:19PM CST
These stocks look ready to break out and trade higher from current levels.

AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:46AM CST
AxoGen was a big mover last session, with shares rising over 25%.

Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options
at The Street - Tue Dec 31, 10:08AM CST
Investors considering a purchase of Achillion Pharmaceuticals Inc. stock, but cautious about paying the going market price of $3.31/share, might benefit from considering selling puts among the alternative strategies at their disposal.

3 Most Horrendous Health-Care Stocks of 2013
Keith Speights, The Motley Fool - Motley Fool - Sat Dec 28, 9:00AM CST
Health-care has been hot in 2013. Not every stock in the sector has sizzled, though. Here are three of the most horrendous health-care stocks of the year. A disappointing fish tale Many investors had high hopes early in 2013 for Amarin . Those...

Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links

ALXN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 308

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading

Top 5 Most Recently Viewed Articles

Aescape Expands into Miami with Privai Spa Partnership

Updated Category News Views 160

Aescape Expands into Miami with Privai Spa Partnership In a thrilling development for luxury wellness, Aescape, known for its automated massage innovations, has teamed up with Privai Spa + Fitness to introduce its services at the famous Kimpton EPIC Hotel in Miami. This exciting collaboration features a fully customizable robotic massage experience that integrates...

Continue Reading
Debating Crypto Regulations: A Look at Elected Officials' Influence

Updated Category News Views 120

Democrats Seek Enhanced Crypto Regulations In recent discussions surrounding the cryptocurrency market structure bill, leading Democrats have expressed a clear intent to impose stricter regulations, particularly concerning stablecoin yield payments. Their aim is to mitigate any potential risks linked to elected officials’ cryptocurrency ventures. This initiative...

Continue Reading
Investors’ Chance to Lead PACS Group Inc. Securities Case

Updated Category News Views 170

Opportunity for Investors in PACS Group Inc. Investors in PACS Group Inc. (NYSE: PACS) are faced with a significant opportunity to join forces in a legal battle against alleged securities fraud. The Rosen Law Firm, recognized for its commitment to investor rights, has announced to all shareholders who acquired PACS common stock that they may now have a chance to seek...

Continue Reading
AvAir Grows Its Inventory with New Wheels and Brakes

Updated Category News Views 116

AvAir Expands Its Inventory with Lufthansa Technik Components New Inventory Includes 1,600 Wheel and Brake Assemblies AvAir, a prominent player in the aviation aftermarket sector, has significantly boosted its inventory by acquiring over 1,600 overhauled wheels and brakes from Lufthansa Technik's spare parts pool. This acquisition builds upon the long-standing...

Continue Reading
Versapay Welcomes Elizabeth Bramlage as New Marketing Leader

Updated Category News Views 323

Versapay Appoints Elizabeth Bramlage as Chief Marketing Officer Versapay has announced the appointment of Elizabeth Bramlage as the new Chief Marketing Officer, aiming to strengthen brand growth and expand its market presence. With a wealth of experience in the fintech and payments landscape, Elizabeth’s leadership will be vital in driving the company's marketing...

Continue Reading